Kura Oncology, Inc. (KURA)

NASDAQ: KURA · IEX Real-Time Price · USD
+0.24 (2.04%)
At close: Mar 27, 2023, 4:00 PM
+0.24 (2.00%)
After-hours: Mar 27, 2023, 7:01 PM EDT

Total Valuation

Kura Oncology has a market cap or net worth of $823.32 million. The enterprise value is $399.15 million.

Market Cap 823.32M
Enterprise Value 399.15M

Important Dates

The next earnings date is Tuesday, May 2, 2023, after market close.

Estimated Earnings Date May 2, 2023
Ex-Dividend Date n/a

Share Statistics

Kura Oncology has 68.44 million shares outstanding. The number of shares has increased by 0.96% in one year.

Shares Outstanding 68.44M
Shares Change (YoY) +0.96%
Shares Change (QoQ) +1.35%
Owned by Insiders (%) 2.75%
Owned by Institutions (%) 106.46%
Float 50.42M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 24.48
PB Ratio 1.96
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 18.56, with a Debt / Equity ratio of 0.03.

Current Ratio 18.56
Quick Ratio n/a
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -30.80% and return on invested capital (ROIC) is -33.80%.

Return on Equity (ROE) -30.80%
Return on Assets (ROA) -29.00%
Return on Capital (ROIC) -33.80%
Revenue Per Employee n/a
Profits Per Employee -$1.07M
Employee Count 127
Asset Turnover n/a
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -27.12% in the last 52 weeks. The beta is 0.93, so Kura Oncology's price volatility has been similar to the market average.

Beta (1Y) 0.93
52-Week Price Change -27.12%
50-Day Moving Average 12.52
200-Day Moving Average 14.31
Average Volume (30 Days) 656,198

Short Selling Information

The latest short interest is 7.10 million, so 10.37% of the outstanding shares have been sold short.

Short Interest 7.10M
Short Previous Month 7.09M
Short % of Shares Out 10.37%
Short % of Float 14.08%
Short Ratio (days to cover) 10.70

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -139.87M
Pretax Income -135.84M
Net Income -135.84M
EBITDA -134.85M
EBIT -135.61M
Earnings Per Share (EPS) -$2.03
Full Income Statement

Balance Sheet

The company has $438.20 million in cash and $14.02 million in debt, giving a net cash position of $424.17 million or $6.20 per share.

Cash & Cash Equivalents 438.20M
Total Debt 14.02M
Net Cash 424.17M
Net Cash Per Share $6.20
Equity / Book Value 420.28M
Book Value Per Share 6.14
Working Capital 422.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$110.06 million and capital expenditures -$626,000, giving a free cash flow of -$110.69 million.

Operating Cash Flow -110.06M
Capital Expenditures -626,000
Free Cash Flow -110.69M
FCF Per Share -$1.65
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Kura Oncology does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -16.50%
FCF Yield -13.44%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -0.96%
Shareholder Yield -0.96%
Dividend Details

Analyst Forecast

The average price target for Kura Oncology is $34.17, which is 184.04% higher than the current price. The consensus rating is "Buy".

Price Target $34.17
Price Target Difference 184.04%
Analyst Consensus Buy
Analyst Count 17
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a